APA (7th ed.) Citation

Chin, H., Horng, C., Liu, Y., Lu, C., Su, C., Chen, P., . . . Yang, J. (2018). Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. Oncology reports, 39(5), 2351-2357. https://doi.org/10.3892/or.2018.6312

Chicago Style (17th ed.) Citation

Chin, Hsien‑Kuo, et al. "Kaempferol Inhibits Angiogenic Ability by Targeting VEGF Receptor-2 and Downregulating the PI3K/AKT, MEK and ERK Pathways in VEGF-stimulated Human Umbilical Vein Endothelial Cells." Oncology Reports 39, no. 5 (2018): 2351-2357. https://doi.org/10.3892/or.2018.6312.

MLA (9th ed.) Citation

Chin, Hsien‑Kuo, et al. "Kaempferol Inhibits Angiogenic Ability by Targeting VEGF Receptor-2 and Downregulating the PI3K/AKT, MEK and ERK Pathways in VEGF-stimulated Human Umbilical Vein Endothelial Cells." Oncology Reports, vol. 39, no. 5, 2018, pp. 2351-2357, https://doi.org/10.3892/or.2018.6312.